PRAMEF5: A Protein Involved in Stress Response and Disease (G343068)

Target Name: PRAMEF5

NCBI ID: G343068

PRAMEF5

Other Name(s): PRAMEF5L | PRAMEF23 | PRAME family member 23 | PRAME family member 5 | PRAM5_HUMAN

PRAMEF5: A Protein Involved in Stress Response and Disease

PRAMEF5 (PRAMEF5L) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. Its full name is primate-specific heat shock protein 5, and it is a member of the heat shock protein (HSP) family.

HSPs are a group of proteins that are expressed in response to increased levels of thermal stress, such as those caused by exercise or infection. They are involved in the regulation of cellular processes that are essential for life, including DNA replication, protein folding, and stress response.

PRAMEF5 is a unique protein because it is only expressed in mammals, and it is not found in any other animals. This makes it an attractive candidate for drug targeting, as researchers can use it as a target for drugs that are specifically designed to interact with it.

One of the key functions of PRAMEF5 is its role in the stress response. When the body experiences stress, the levels of PRAMEF5 increase, and this increase is associated with a number of beneficial effects. For example, increased levels of PRAMEF5 have been observed in response to stress, including increased protein synthesis and DNA replication.

In addition to its role in stress response, PRAMEF5 is also involved in the regulation of protein folding. Proteins are complex structures that are made up of multiple amino acids, and they must be fold in specific ways in order to have the correct function. PRAMEF5 is involved in the regulation of the folding of certain proteins, and its absence has been linked to a number of diseases, including neurodegenerative disorders.

Another function of PRAMEF5 is its role in the regulation of cell death. When cells are no longer able to function properly, they may undergo programmed cell death, also known as apoptosis. PRAMEF5 is involved in the regulation of apoptosis, and its absence has been linked to the development of certain diseases.

In addition to its role in stress response, PRAMEF5 is also involved in the regulation of protein synthesis and cell death. It is a protein that is expressed in response to increased levels of thermal stress, and it is involved in the regulation of protein synthesis and the regulation of cell death.

As a potential drug target, PRAMEF5 is an attractive candidate for interventions that are aimed at treating a variety of diseases. For example, PRAMEF5 has been suggested as a potential therapeutic for a number of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential therapeutic applications, PRAMEF5 is also an important biomarker for a number of diseases. Its levels are often elevated in response to the development of certain diseases, and its levels have been used as a diagnostic marker in a number of studies.

Overall, PRAMEF5 is a protein that is expressed in various tissues of the body and is involved in a number of important cellular processes. Its potential as a drug target makes it an attractive candidate for intervention in a variety of diseases. Further research is needed to fully understand the role of PRAMEF5 in cellular processes and its potential as a therapeutic.

Protein Name: PRAME Family Member 5

The "PRAMEF5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRAMEF5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets